| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,236 |
5,041 |
$474K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,226 |
940 |
$174K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,471 |
2,042 |
$124K |
| 96127 |
|
2,171 |
1,872 |
$43K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
868 |
798 |
$20K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
215 |
184 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
208 |
185 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
187 |
136 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
299 |
220 |
$12K |
| 96160 |
|
694 |
489 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
281 |
220 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
596 |
488 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
449 |
242 |
$8K |
| 99215 |
Prolong outpt/office vis |
73 |
60 |
$7K |
| 92551 |
|
343 |
274 |
$5K |
| 90686 |
|
463 |
387 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
58 |
39 |
$4K |
| 85018 |
|
1,506 |
1,235 |
$3K |
| 83718 |
|
368 |
285 |
$3K |
| 90674 |
|
114 |
101 |
$2K |
| 36416 |
|
460 |
389 |
$2K |
| 82465 |
|
352 |
288 |
$1K |
| 94760 |
|
363 |
287 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
19 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
83 |
71 |
$1K |
| 99173 |
|
163 |
140 |
$1K |
| 90661 |
|
68 |
60 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
66 |
53 |
$963.60 |
| 83655 |
|
65 |
45 |
$770.90 |
| 99174 |
|
55 |
41 |
$394.85 |
| 90670 |
|
41 |
28 |
$386.32 |
| 90651 |
|
20 |
13 |
$364.78 |
| 81002 |
|
53 |
40 |
$137.80 |
| 90698 |
|
12 |
12 |
$76.80 |